Redhill Biopharma Stock Alpha and Beta Analysis
| RDHL Stock | USD 2.56 0.04 1.54% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Redhill Biopharma. It also helps investors analyze the systematic and unsystematic risks associated with investing in Redhill Biopharma over a specified time horizon. Remember, high Redhill Biopharma's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Redhill Biopharma's market risk premium analysis include:
Beta 1.21 | Alpha (1.27) | Risk 4.09 | Sharpe Ratio (0.41) | Expected Return (1.67) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Redhill |
Redhill Biopharma Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Redhill Biopharma market risk premium is the additional return an investor will receive from holding Redhill Biopharma long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Redhill Biopharma. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Redhill Biopharma's performance over market.| α | -1.27 | β | 1.21 |
Redhill Biopharma expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Redhill Biopharma's Buy-and-hold return. Our buy-and-hold chart shows how Redhill Biopharma performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Redhill Biopharma Market Price Analysis
Market price analysis indicators help investors to evaluate how Redhill Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Redhill Biopharma shares will generate the highest return on investment. By understating and applying Redhill Biopharma stock market price indicators, traders can identify Redhill Biopharma position entry and exit signals to maximize returns.
Redhill Biopharma Return and Market Media
The median price of Redhill Biopharma for the period between Sun, Dec 15, 2024 and Sat, Mar 15, 2025 is 5.88 with a coefficient of variation of 24.42. The daily time series for the period is distributed with a sample standard deviation of 1.37, arithmetic mean of 5.62, and mean deviation of 1.07. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Stocks To Watch Quantum Biopharma Sees Relative Strength Rating Jump To 91 | 02/11/2025 |
2 | Wall Street Analysts Predict a 127.26 percent Upside in Benitec Biopharma Heres What You Should Know | 02/20/2025 |
3 | Xeris Biopharma to Report Fourth Quarter and Full-Year 2024 Financial Results on March 6, 2025 | 02/27/2025 |
4 | Be Biopharma Announces Appointment of Susan Abu-Absi, Ph.D. as Chief Operating Officer | 03/03/2025 |
5 | Guillain-Barr Syndrome Drug Development Pipeline Research Report 2025 Featuring Annexon and Hansa Biopharma | 03/04/2025 |
6 | EyePoint Pharmaceuticals Reports Q4 Loss, Lags Revenue Estimates | 03/05/2025 |
7 | Xeris Biopharma Delivers Record Fourth Quarter and Full-Year 2024 Results and Announces 2025 Guidance | 03/06/2025 |
8 | BIO-Europe Spring 2025 Partnering is Surging - All Roads Lead to Milan for Biopharmas Premier Springtime Event | 03/07/2025 |
9 | Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian 200 ... | 03/10/2025 |
10 | Xeris Biopharma - Possibly The Best Pharma Stock | 03/11/2025 |
11 | Short Interest in RedHill Biopharma Ltd. Rises By 486.2 | 03/12/2025 |
12 | Is GC Biopharma Corp. Trading At A percent Discount | 03/13/2025 |
About Redhill Biopharma Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Redhill or other stocks. Alpha measures the amount that position in Redhill Biopharma has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2024 | 2025 (projected) | Graham Number | 4.64 | 4.12 | Receivables Turnover | 1.78 | 1.89 |
Redhill Biopharma Upcoming Company Events
As portrayed in its financial statements, the presentation of Redhill Biopharma's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Redhill Biopharma's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Redhill Biopharma's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Redhill Biopharma. Please utilize our Beneish M Score to check the likelihood of Redhill Biopharma's management manipulating its earnings.
| 26th of April 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Build Portfolio with Redhill Biopharma
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Redhill Biopharma Backtesting, Redhill Biopharma Valuation, Redhill Biopharma Correlation, Redhill Biopharma Hype Analysis, Redhill Biopharma Volatility, Redhill Biopharma History and analyze Redhill Biopharma Performance. For more information on how to buy Redhill Stock please use our How to buy in Redhill Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Redhill Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.